Stresswin in Hypertensio
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2023/05/052806
- Lead Sponsor
- IOE, BH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients willing to participate in the study.
2.Patients of either sex with ages between 18-60 years.
3.Patients having Hypertension between the time intervals of 6 months to 1 year.
4.Patients suffering from Stage I Hypertension (Systolic Blood Pressure 140-159mm of Hg, Diastolic Blood Pressure 90-99mm of Hg)
5.Patients suffering from Stage I Hypertension are those who are on allopathic medicines.
6.Patients suffering from Isolated Systolic Hypertension.
1.Patients not willing to participate in the study.
2.Patients of either sex below 18 years & above 60 years will be excluded from the study.
3.Patients having Hypertension for <6 months and >1 year will be excluded.
4.Patients of Stage II Hypertension (Systolic Blood Pressure >160mmHg and Diastolic Blood Pressure >100mmHg)
5.Patients suffering from serious comorbidities like renal failure, coronary artery disease, Type 2 Diabetes Mellitus, cervical spondylosis, taking medications/drugs (oral contraceptives, steroids, chronic use of NSAIDs etc.).
6.Alcoholics and/or drug abusers.
7.History of hypersensitivity to the trial drug or any of its ingredients.
8.Pregnant/ lactating woman.
9.Patients who have completed participation in any other clinical trial during the past 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ormalization of Blood Pressure within one month of interventionTimepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method Reduce Stress <br/ ><br>Sound sleep <br/ ><br>Reduce Palpitations <br/ ><br>Timepoint: 1 week